TOTAL HEALTH INSIGHT Powered by Consultative AnalyticsSM

Slides:



Advertisements
Similar presentations
Congratulations on signing up with kynect. Choose a primary care provider and make an appointment for overall wellness checks to prevent sickness.
Advertisements

Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
Session 1 (tutorial session): Radiation and Thyroid Cancer Summary Many patients with thyroid cancer were found in the Fukushima Health Management survey.
Daniel Altman, David Cutler, Richard Zeckhauser “Enrollee mix, treatment intensity, and cost in competing indemnity and HMO plans” Journal of Health Economics.
Payment and Delivery Reform: Building a Bridge to the Future
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
Michigan Quality Improvement Consortium Measurement Committee Year-End Report December 14, 2006.
2010 Pay for Performance (P4P) Program Training for Participants.
LOCKTON DUNNING BENEFITS UNIVERSITY OF ALASKA 2ND QTR FY13 UTILIZATION REVIEW 7/1/2012 TO 12/31/2012.
Health Challenge John Greensill. Current arrangements A fully integrated Health and Social Care Service funded 50:50 by NHS Walsall and Walsall Council.
Introduction to general dermatology- history, examination and terminology. Acne vulgaris Nagla Konbor Medical Students Teaching, 23/04/2013.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
Health Disparities in cancer screening and prevention A novel approach to community outreach for at risk communities.
K ENTUCKY Cabinet for Health and Family Services Kentucky Department for Medicaid Services Lisa D. Lee, Commissioner November 20, 2015.
Quality December 7, 2005 Charles Milligan, JD, MPH Adequate Health Care Task Force.
Copyright © Body Active Consultancy Presented By: Body Active Consultancy APOSHO Western Australia 2011.
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
Decoding the USPSTF By: Dr Vikram Arora Heritage Valley Health System.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.
What does the data tell us? Colorectal CANCER IN NEVADA
World Cancer Day 2017 We Can, I Can Do you know this?
Indiana State Cancer Registry
BCAM 2017 Campaign Overview
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
War on cancer , year 40: who’s winning?
Incidence and Treatment Patterns in Hospitalizations for Malignant Spinal Cord Compression in the United States, 1998–2006  Kimberley S. Mak, B.A., Leslie.
For more information please visit
2016 Annual Data Report, Vol 1, CKD, Ch 7
Exhibit 1 Adults with High Needs Have Higher Health Care Spending and Out-of-Pocket Costs Average annual out-of-pocket spending Average annual health.
Multinational Comparisons of Health Systems Data, 2011
Non-Communicable Diseases Risk Factors Survey in Georgia
OVERALL LEADING CAUSES OF DEATH IN THE USA
Of Adults with High Costs, Most Have Multiple Chronic Diseases, With or Without Functional Limitations Percent with high needs: Three or more chronic diseases,
Copyright © 2015 American Medical Association. All rights reserved.
Total adult population
Chapter 7: Prescription Drug Coverage in Patients with CKD
Are Group Insurance Benefits Becoming Unaffordable?
EPID 503 – Class 6 Standardization.
University of Witwatersrand, Johannesburg, South Africa
CCIC 2018 Member Forum Using Data to Reduce Costs and Improve Health
Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Breast is for female only. Laryngeal is for.
سرطان الثدي Breast Cancer
INCIDENCE.
8_84 Apollo Sugar Clinic: Diabetes surveillance campaign Screening Population Based on Gender Apollo Sugar holds the Proprietary right for the content.
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
Average annual out-of-pocket spending
Top Claimed Contentions
Fort Atkinson School District Wellness Program
Standard 3.1 Patient Navigation Process
Are You Totally Protected?.
Prevalence of Male and Female Pattern Hair Loss in Maryborough
Percent of women ages 19–64 Total <133% FPL 133%–249% FPL
National Cancer Statistics in Korea, 2015
Profile of breast cancer patients receiving government sponsored free treatment and the associated economic costs  Sumita Shankar, Manaswitha Boyanagari,
Suicide data for Scotland (2006 – 2016)
OVERALL LEADING CAUSES OF DEATH IN THE USA
American Journal of Kidney Diseases
The failure of breast cancer screening
ESTIMATING THE EFFICIENCY OF THREE NATIONAL CANCER SCREENING PROGRAMMES USING THE POPULATION-BASED CANCER REGISTRY DATA IN SLOVENIA Vesna ZADNIK MD,
BEHAVIORAL HEALTH AND OPIOId ADDICTION
Mount Auburn Medical Associates
Community Learning Session #4 March 4, 2016
Ely South PCN Data pack August 2019.
Ely North PCN Data pack August 2019.
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Progress on select dashboard measures as of December 31, 2017.
Presentation transcript:

TOTAL HEALTH INSIGHT Powered by Consultative AnalyticsSM December 2, 2016 Copyright 2016 Cigna – Confidential & Privileged – Not for Distribution

Population/Percentile Cost Profile                                                                                                                                            What portion of the population drives your healthplan costs of $141.4 Million? Top 1% of claimants:    284 individuals    34% of total cost    $47.4 Million Total medical cost vs. % of Population Top 5% of claimants: 100% 85%   1,422 individuals   59% of total cost 80% 72%   $83.2 Million % of Total plan spend 59%                                                                                                                                                                            60% Top 10% of claimants: 34%   2,844 individuals 40%   72% of total cost   $101.8 Million 20% 0% Top 20% of claimants: Top 1% Top 5% Top 10% Top 20%    5,689 individuals    85% of total cost % of Population    $120.0 Million Current Period reflects claims incurred between Sep. 2015 and Aug. 2016, paid through Oct. 2016 Base Period reflects claims incurred between Sep. 2014 and Aug. 2015, paid through Oct. 2015

Cancer Cost Per Patient Cancer Summary Cancer prevalence by age band Prevalence and cost by condition Condition # of Members Prevalence Cancer Cost Per Patient Total Plan Spend Breast 174 0.7% $30,165 $5,248,653 20.0% Male Rep. 115 0.5% $16,083 $1,849,569 15.0% Female Rep. 61 0.2% $17,377 $1,060,018 Neoplastic Disease 59 0.2% $50,517 $2,980,532 10.0% Dermatology 41 0.2% $2,258 $92,576 Gastrointestinal 33 0.1% $34,643 $1,143,225 5.0% Thyroid 18 0.1% $13,641 $245,530 Central Nervous 15 0.1% $10,853 $162,799 0.0% Rectum 14 0.1% $49,597 $694,354 <01 1-17 18-29 30-39 40-49 50-59 60-64 65+ Other 51 0.2% $40,529 $2,067,003     Male 0.0% 0.1% 0.1% 0.3% 1.6% 3.8% 7.9% 16.7% Total 550 2.2% $28,262 $15,544,259     Female 0.0% 0.1% 0.6% 0.8% 2.3% 4.8% 7.6% 14.8% Cancer screening rates   · 550 individuals with eligibility in the current period had a cancer episode, or 2.2% prevalence    · Average cost per patient for these episodes was $28,262 for a total of $15,544,259    · The primary cancer type was Breast with 0.7% prevalence and $5,248,653 in total plan spend 80% 60% 40% 20% 0% Breast Cancer Cervical Cancer Colon Cancer     Current 58% 60% 34%     Norm 60% 58% 47% Current Period reflects claims incurred between Sep. 2015 and Aug. 2016, paid through Oct. 2016